Risk of death following application of paclitaxel‐coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta‐analysis of …
Background Several randomized controlled trials (RCT s) have already shown that
paclitaxel‐coated balloons and stents significantly reduce the rates of vessel restenosis and …
paclitaxel‐coated balloons and stents significantly reduce the rates of vessel restenosis and …
2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American …
MD Gerhard-Herman, HL Gornik, C Barrett… - Journal of the American …, 2017 - jacc.org
The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …
initial extensive evidence review, which included literature derived from research involving …
[PDF][PDF] 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
W 2011 roku ESC opublikowało pierwsze wytyczne dotyczące rozpoznawania i leczenia
chorób tętnic obwodowych (PAD)[1]. Ta publikacja wypełniła ważną lukę wśród wytycznych …
chorób tętnic obwodowych (PAD)[1]. Ta publikacja wypełniła ważną lukę wśród wytycznych …
Editor's Choice–2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery …
Document Reviewers b, Petr Widimsky, Philippe Kolh, Stefan Agewall, Héctor Bueno,
Antonio Coca, Gert J. De Borst, Victoria Delgado, Florian Dick, Cetin Erol, Marc Ferrini …
Antonio Coca, Gert J. De Borst, Victoria Delgado, Florian Dick, Cetin Erol, Marc Ferrini …
Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial
MD Dake, GM Ansel, MR Jaff, T Ohki, RR Saxon… - Circulation, 2016 - Am Heart Assoc
Background—This randomized controlled trial evaluated clinical durability of Zilver PTX, a
paclitaxel-coated drug-eluting stent (DES), for femoropopliteal artery lesions. Outcomes …
paclitaxel-coated drug-eluting stent (DES), for femoropopliteal artery lesions. Outcomes …
Trial of a paclitaxel-coated balloon for femoropopliteal artery disease
K Rosenfield, MR Jaff, CJ White… - … England Journal of …, 2015 - Mass Medical Soc
Background The treatment of peripheral artery disease with percutaneous transluminal
angioplasty is limited by the occurrence of vessel recoil and restenosis. Drug-coated …
angioplasty is limited by the occurrence of vessel recoil and restenosis. Drug-coated …
Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month …
G Tepe, J Laird, P Schneider, M Brodmann… - Circulation, 2015 - Am Heart Assoc
Background—Drug-coated balloons (DCBs) have shown promise in improving the
outcomes for patients with peripheral artery disease. We compared a paclitaxel-coated …
outcomes for patients with peripheral artery disease. We compared a paclitaxel-coated …
Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis
E Freisinger, J Koeppe, J Gerss… - European Heart …, 2020 - academic.oup.com
Aims Drug-eluting devices (DED) represent a well-established therapy being widely used for
endovascular revascularization (EVR) of peripheral vessels. Recent data indicate a two-fold …
endovascular revascularization (EVR) of peripheral vessels. Recent data indicate a two-fold …
Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease
F Fanelli, A Cannavale, M Gazzetti, P Lucatelli… - Cardiovascular and …, 2014 - Springer
Purpose This study was designed to assess the effect of calcium on the efficacy of DEB
during revascularization of steno-obstructive SFA lesions. Methods Sixty patients with de …
during revascularization of steno-obstructive SFA lesions. Methods Sixty patients with de …
Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN. PACT SFA randomized trial
PA Schneider, JR Laird, G Tepe… - Circulation …, 2018 - Am Heart Assoc
Background—Randomized controlled trials have reported favorable 1-year outcomes with
drug-coated balloons (DCBs) for the treatment of symptomatic peripheral arterial disease …
drug-coated balloons (DCBs) for the treatment of symptomatic peripheral arterial disease …